These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12795655)

  • 1. Limitations to subcutaneous insulin administration in type 1 diabetes.
    Chen JW; Christiansen JS; Lauritzen T
    Diabetes Obes Metab; 2003 Jul; 5(4):223-33. PubMed ID: 12795655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Soluble long-acting insulin analogues].
    Yokono K
    Nihon Rinsho; 1997 Nov; 55 Suppl():306-9. PubMed ID: 9434485
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired absorption of insulin aspart from lipohypertrophic injection sites.
    Johansson UB; Amsberg S; Hannerz L; Wredling R; Adamson U; Arnqvist HJ; Lins PE
    Diabetes Care; 2005 Aug; 28(8):2025-7. PubMed ID: 16043749
    [No Abstract]   [Full Text] [Related]  

  • 5. [From human insulin to designer insulin. Why insulin analogs?].
    Jungmann E
    Fortschr Med; 1997 Apr; 115(12):40-1. PubMed ID: 9235302
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe insulin resistance treated with insulin lispro.
    Gill G; Williams G
    Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current insulin therapy. Treatment with new short-acting and retard insulin analogs].
    Matthaei S; Hamann A
    Fortschr Med; 1997 Apr; 115(12):35-6, 39. PubMed ID: 9235301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug delivery system for diabetes].
    Yamasaki Y
    Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarification of the similarities and differences among insulin analog preparations: response to Becker.
    Meneghini LF
    Diabetes Technol Ther; 2008 Feb; 10(1):51-3; author reply 54-6. PubMed ID: 18275364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin treatment of type 1 diabetes in adults].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):776-8. PubMed ID: 16541173
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.
    Rosenstock J; Owens D
    Expert Opin Pharmacother; 2004 Jan; 5(1):1-2; author reply 2-3. PubMed ID: 14680430
    [No Abstract]   [Full Text] [Related]  

  • 12. Selecting an insulin program for type 1 diabetes.
    Scheiner G
    Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation.
    Lee SI; Narendran P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NICE recommends insulin pumps for young people only if injections impractical.
    Dinsdale P
    BMJ; 2008 Jul; 337():a1067. PubMed ID: 18664508
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
    Maiorino MI; Petrizzo M; Bellastella G; Esposito K
    Endocrine; 2018 Jan; 59(1):62-65. PubMed ID: 28551774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 17. New Options in Insulin Therapy.
    Saraiya N; Martin ST
    Conn Med; 2015 Oct; 79(9):553-60. PubMed ID: 26630709
    [No Abstract]   [Full Text] [Related]  

  • 18. Lispro, a rapid-onset insulin.
    Med Lett Drugs Ther; 1996 Oct; 38(986):97-8. PubMed ID: 8906134
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
    Blumer I
    Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetic patient with insulin analog treatment. More flexible meal regimen].
    MMW Fortschr Med; 2001 Feb; 143(7):60. PubMed ID: 11268756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.